Anne White

Anne White (she/her) is the executive vice president and president of Lilly Neuroscience. Anne has held a range of leadership roles across multiple therapeutic areas, including oncology, neuroscience and infectious disease. She has led the development of multiple late-phase opportunities and has led teams in the submission, approval and launch of several new medicines. She also led Lilly’s successful effort to significantly speed drug development from target identification through product launch. Anne served most recently as senior vice president of Eli Lilly and Company and president of Lilly Oncology, with prior roles in R&D Leadership.